Nilotinib Meets Primary Endpoint in Pivotal Trial Against Imatinib as First-Line Treatment in Chronic Myeloid Leukemia Patients.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 12, p. 1104
- Publication type:
- Article
Works matching DE "NOVARTIS AG"
Results: 485
1
2
Announcements.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 12, p. 1545
- Publication type:
- Article
3
Announcements.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 9, p. 1117
- Publication type:
- Article
4
Clinical Imaging: Focus on Service.
- Published in:
- Bio-IT World, 2011, v. 10, n. 4, p. 33
- By:
- Publication type:
- Article
5
Summer Heat.
- Published in:
- Bio-IT World, 2011, v. 10, n. 4, p. 5
- By:
- Publication type:
- Article
6
Novel IT Platform Helps Novartis Gain Control of Clinical Imaging Data.
- Published in:
- Bio-IT World, 2010, v. 9, n. 6, p. 16
- By:
- Publication type:
- Article
7
The Italian (Informatics) Job.
- Published in:
- Bio-IT World, 2010, v. 9, n. 1, p. 5
- By:
- Publication type:
- Article
8
Novartis Savors Early Modeling Success.
- Published in:
- Bio-IT World, 2009, v. 8, n. 3, p. 32
- By:
- Publication type:
- Article
9
India Becoming Favored Destination for Clinical Trials.
- Published in:
- Bio-IT World, 2008, v. 7, n. 2, p. 33
- By:
- Publication type:
- Article
10
SYSTEMS BIOLOGY'S Awkward Adolescence.
- Published in:
- Bio-IT World, 2007, v. 6, n. 7, p. 20
- By:
- Publication type:
- Article
11
Briefs.
- Published in:
- Bio-IT World, 2007, v. 6, n. 7, p. 12
- Publication type:
- Article
12
Briefs.
- Published in:
- Bio-IT World, 2007, v. 6, n. 3, p. 15
- Publication type:
- Article
13
Novartis' Answer to Harry Potter.
- Published in:
- Bio-IT World, 2006, v. 5, n. 10, p. 24
- By:
- Publication type:
- Article
14
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 3, p. 12
- Publication type:
- Article
15
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 3, p. 18
- Publication type:
- Article
16
News Blast.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 12
- Publication type:
- Article
17
'E-source' Is Coming, Experts Say.
- Published in:
- Bio-IT World, 2005, v. 4, n. 7, p. 36
- By:
- Publication type:
- Article
18
News Blast.
- Published in:
- Bio-IT World, 2005, v. 4, n. 5, p. 10
- Publication type:
- Article
19
Pharma Awards Achievement.
- Published in:
- Bio-IT World, 2004, v. 3, n. 9, p. 12
- By:
- Publication type:
- Article
20
Master of the EDC Universe.
- Published in:
- 2004
- By:
- Publication type:
- Interview
21
The Gleevec Chronicles.
- Published in:
- Bio-IT World, 2004, v. 3, n. 7, p. 43
- By:
- Publication type:
- Article
22
Turning Sugar into Science.
- Published in:
- Bio-IT World, 2004, v. 3, n. 5, p. 58
- By:
- Publication type:
- Article
23
PCs United.
- Published in:
- Bio-IT World, 2004, v. 3, n. 3, p. 50
- Publication type:
- Article
24
Genomics Provides the Kick Inside.
- Published in:
- Bio-IT World, 2003, v. 2, n. 11, p. 28
- By:
- Publication type:
- Article
25
Matter Makes Move to Singapore.
- Published in:
- Bio-IT World, 2003, v. 2, n. 10, p. 10
- By:
- Publication type:
- Article
26
Gridlock Is a Good Thing at Novartis.
- Published in:
- Bio-IT World, 2003, v. 2, n. 10, p. 10
- By:
- Publication type:
- Article
27
TARGETING Tumors.
- Published in:
- Bio-IT World, 2003, v. 2, n. 8, p. 40
- By:
- Publication type:
- Article
28
CLINICAL TRIALS PARTICIPANTS.
- Published in:
- 2003
- Publication type:
- Other
29
EDC Needs a Big Boot.
- Published in:
- Bio-IT World, 2003, v. 2, n. 4, p. 94
- By:
- Publication type:
- Article
30
One year on - Novartis, DST and SAMRC MoU builds scientific capability in South Africa.
- Published in:
- SA Pharmaceutical Journal Incorporating Pharmacy Management, 2018, v. 85, n. 4, p. 83
- Publication type:
- Article
31
Impact of Treatment with Imatinib on Renal Histology in Albino Rats.
- Published in:
- Jordan Medical Journal, 2020, v. 54, n. 3, p. 99
- By:
- Publication type:
- Article
32
Bioinformatic Strategies for Better Understanding of Immune Function.
- Published in:
- In Silico Biology, 2003, v. 3, n. 4, p. 411, doi. 10.3233/isb-00105
- By:
- Publication type:
- Article
33
India.
- Published in:
- Journal of Global Health, 2013, v. 3, n. 1, p. 9, doi. 10.7189/jogh.03.010201
- Publication type:
- Article
34
Compliance After China's Healthcare Bribery Scandals.
- Published in:
- China Business Review, 2013, p. 11
- By:
- Publication type:
- Article
35
BAUTECHNIK aktuell 6/22.
- Published in:
- Bautechnik, 2022, v. 99, n. 6, p. 491, doi. 10.1002/bate.202270604
- Publication type:
- Article
36
ethical products.
- Published in:
- 2011
- Publication type:
- Product Review
37
PRODUCT NEWS.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1092, p. 46
- Publication type:
- Article
38
ETHICAL PRODUCTS.
- Published in:
- 2010
- Publication type:
- Product Review
39
Awards recognise sector's prime movers.
- Published in:
- Australian Journal of Pharmacy, 2009, v. 90, n. 1070, p. 52
- Publication type:
- Article
40
INDIA'S CRACK DOWN ON THE PRACTICE OF PHARMACEUTICAL EVERGREENING: THE 2013 NOVARTIS DECISION.
- Published in:
- UMKC Law Review, 2016, v. 85, n. 1, p. 503
- By:
- Publication type:
- Article
41
Approval may embolden industry to combine cancer therapies.
- Published in:
- Nature Medicine, 2015, v. 21, n. 2, p. 105, doi. 10.1038/nm0215-105
- By:
- Publication type:
- Article
42
Infectious disease leads in first phase of Europe's IMI effort.
- Published in:
- Nature Medicine, 2014, v. 20, n. 1, p. 5, doi. 10.1038/nm0114-5
- Publication type:
- Article
43
Drugs that made headlines in 2013.
- Published in:
- Nature Medicine, 2013, v. 19, n. 12, p. 1562, doi. 10.1038/nm1213-1562
- Publication type:
- Article
44
Cell-based vaccines yield only modest advances for seasonal flu.
- Published in:
- Nature Medicine, 2013, v. 19, n. 1, p. 4, doi. 10.1038/nm0113-4
- By:
- Publication type:
- Article
45
Beyond cost considerations.
- Published in:
- Nature Medicine, 2012, v. 18, n. 6, p. 835, doi. 10.1038/nm.2842
- Publication type:
- Article
46
Brazilian drug companies hope to benefit from foreign investment.
- Published in:
- Nature Medicine, 2011, v. 17, n. 10, p. 1171, doi. 10.1038/nm1011-1171a
- By:
- Publication type:
- Article
47
Companies compete over mutation-specific melanoma drugs.
- Published in:
- Nature Medicine, 2011, v. 17, n. 3, p. 268, doi. 10.1038/nm0311-268a
- By:
- Publication type:
- Article
48
Road rules for drugs: a survey of signals.
- Published in:
- Nature Medicine, 2010, v. 16, n. 12, p. 1362, doi. 10.1038/nm1210-1362
- Publication type:
- Article
49
News in brief.
- Published in:
- Nature Medicine, 2009, v. 15, n. 12, p. 1344, doi. 10.1038/nm1209-1344
- Publication type:
- Article
50
Straight talk from... James Love.
- Published in:
- 2007
- By:
- Publication type:
- Question & Answer